Progression of radiographic joint erosion during low dose corticosteroid treatment of rheumatoid arthritis.

Abstract

Clinically indicated low dose prednisone did not prevent progressive radiographic damage in 197 NSAID treated patients whose physicians had initiated < or =5 mg daily before study entry. The risk/benefit ratio of chronic low dose prednisone in early RA remains uncertain.